Join
Live feed
·
PRReleasevia Quantisnow
Zai Lab Limited logo

Zai Lab to Present Data From First Clinical Trial Evaluating ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, for Atopic Diseases

ByQuantisnow·Wall Street's wire, on your screen.
ZLAB· Zai Lab Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZLAB (Zai Lab Limited) and more on Quantisnow.